Inventor · disambiguated record
Heinz Peter Vollmers
Also filed as: VOLLMERS HEINZ · VOLLMERS HEINZ P · VOLLMERS HEINZ PETER
12 granted patents·14 pending applications·15 citations·filing 1999–2014
86Inventor score
Files withPATRYS LTD11VOLLMERS HEINZ-PETER6DEBIOVISION INC3DEBIOVISION1MUEELLER-HERMELINK HANS-KONRAD1
Top patents by PatentIndex Score
26 records- 0175US8741296B2Adenocarcinoma specific antibody SAM-6, and uses thereofVOLLMERS HEINZ PETER·Filed 2012·Granted Jun 3, 2014·2 cites·16 claims
- 0269US8562995B2Neoplasm specific antibodies and uses thereofMUEELLER-HERMELINK HANS-KONRAD·Filed 2011·Granted Oct 22, 2013·3 cites·7 claims
- 0369US7741444B2Neoplasm specific antibodies and uses thereofPATRYS LTD·Filed 2007·Granted Jun 22, 2010·1 cites·19 claims
- 0466US9273125B2Human monoclonal antibody having fat-reducing effectVOLLMERS HEINZ PETER·Filed 2012·Granted Mar 1, 2016·1 cites·12 claims
- 0564US2008199475A1Novel glycosylated peptide target in neoplastic cellsPATRYS LTD·Filed 2007·Application pending·0 cites
- 0663US8124080B2Human monoclonal antibody having fat-reducing effectVOLLMERS HEINZ PETER·Filed 2004·Granted Feb 28, 2012·2 cites·27 claims
- 0762US8163552B2Adenocarcinoma specific antibody SAM-6, and uses thereofVOLLMERS HEINZ·Filed 2004·Granted Apr 24, 2012·1 cites·23 claims
- 0861US7947812B2Neoplasm specific antibodies and uses thereofPATRYS LTD·Filed 2004·Granted May 24, 2011·2 cites·24 claims
- 0959US2010322936A1Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using samePATRYS LTD·Filed 2009·Application pending·0 cites
- 1058US7378247B2Neoplasm-specific polypeptides and their usesDEBIOVISION INC·Filed 2004·Granted May 27, 2008·2 cites·8 claims
- 1157US2009202570A1Pm-2 antibodies, functional fragments and methods for treating metastasisPATRYS LTD·Filed 2008·Application pending·0 cites
- 1256US2010316630A1Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and useVOLLMERS HEINZ PETER·Filed 2009·Application pending·0 cites
- 1354US7611894B2Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and useDEBIOVISION·Filed 2004·Granted Nov 3, 2009·1 cites·6 claims
- 1452US2005208056A1Neoplasm specific antibodies and uses thereofVOLLMERS HEINZ P·Filed 2003·Application pending·0 cites
- 1551US9783599B2LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using samePATRYS LTD·Filed 2014·Granted Oct 10, 2017·0 cites·4 claims
- 1651US2009136420A1Neoplasm-specific polypeptides and their usesDEBIOVISION INC·Filed 2008·Application pending·0 cites
- 1751US2007244304A1Methods of Identifying Neoplasm-Specific Antibodies and Uses ThereofONCOMAB GMBH·Filed 2004·Application pending·0 cites
- 1850US7772372B2Neoplasm specific antibodies and uses thereofPATRYS LTD·Filed 2003·Granted Aug 10, 2010·0 cites·22 claims
- 1948US2011076763A1Neoplasm specific antibodies and uses thereofPATRYS LTD·Filed 2010·Application pending·0 cites
- 2044US2013101588A1Novel glycosylated peptide target in neoplastic cellsVOLLMERS HEINZ PETER·Filed 2010·Application pending·0 cites
- 2144US2010317826A1Neoplasm specific antibodies and uses thereofPATRYS LTD·Filed 2010·Application pending·0 cites
- 2243US2009291083A1Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using samePATRYS LTD·Filed 2009·Application pending·0 cites
- 2342US2009258020A1Antibody designated barb3, barb3 related antibodies, and methods of making and using samePATRYS LTD·Filed 2009·Application pending·0 cites
- 2439US2011027182A1Substance for obtaining highly effective tumor medications as well as a processVOLLMERS HEINZ-PETER·Filed 2010·Application pending·0 cites
- 2536US2008281083A1Antigen of the Pm-2 Antibody and Use ThereofPATRYS PTY LTD·Filed 2005·Application pending·0 cites
- 2625US7767787B1Substance for obtaining highly effective tumor medications as well as a processDEBIOVISION INC·Filed 1999·Granted Aug 3, 2010·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Heinz Peter Vollmers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →